Qube Research & Technologies LTD Theravance Biopharma, Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding TBPH
# of Institutions
124Shares Held
49.6MCall Options Held
1.4KPut Options Held
2.3K-
Weiss Asset Management LP Boston, MA7.46MShares$62 Million2.91% of portfolio
-
Madison Avenue Partners, LP New York, NY7.01MShares$58.3 Million12.55% of portfolio
-
Seth Klarman Baupost Group LLC | Boston, Ma6.59MShares$54.9 Million1.62% of portfolio
-
Black Rock Inc. New York, NY4.21MShares$35 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$23 Million5.05% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $556M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...